GMP Beta-Amyloid (1-40), human

Ab (1-40) together with Ab (1-42) are two major C-terminal variants of the Ab protein constituting the majority of Abs. These undergo post-secretory aggregation and deposition in the Alzheimer’s disease brain.
This cGMP beta-Amyloid 1-40 peptide has been produced under conditions compliant with 21 CFR part 820 & ISO 13485 and is appropriate for use as an IVD component or as a quality control standard (not for human use).

QC attributes

Peptide Purity: =95%

Endotoxin: =1 EU/mg

Bioburden: Report Results (Lot specific)

Solubility: Report Results (Lot specific)

Monomer content: Report Results (Lot specific)